Submit Article
Legal Analysis. Regulatory Intelligence. Jurisprudence.
Search articles, case studies, legal topics...
Singapore

NOOR AZLIN BINTE ABDUL RAHMAN v CHANGI GENERAL HOSPITAL PTE LTD & 3 Ors

300 wpm
0%
Chunk
Theme
Font

Case Details

  • Citation: [2018] SGHC 35 (eLitigation)
  • Case Number: HC/Suit No 59 of 2015
  • Decision Date: 14 February 2018
  • Court: High Court of Singapore
  • Coram: Belinda Ang Saw Ean J
  • Judgment Delivered By: Belinda Ang Saw Ean J
  • Appellant(s): Noor Azlin Binte Abdul Rahman (Plaintiff)
  • Respondent(s): Changi General Hospital Pte Ltd (First Defendant); Imran bin Mohamed Noor (Second Defendant); Yap Hsiang (Third Defendant); Soh Wei Wen Jason (Fourth Defendant)
  • Counsel for Appellant: Vijay Kumar Rai (Engelin Teh Practice LLC)
  • Counsel for Respondent: Kuah Boon Theng, SC, Karen Yong and Samantha Oei (Legal Clinic LLC) for the First Defendant; Lek Siang Pheng, Vanessa Lim, Yvonne Ong and Audrey Sim (Dentons Rodyk & Davison LLP) for the Second to Fourth Defendants
  • Legal Areas: Tort; Negligence; Medical Negligence; Breach of Duty; Causation
  • Statutes Referenced: Evidence Act (Cap 97, 1997 Rev Ed)
  • Key Provisions: Evidence Act, ss 103(1), 104, 105
  • Disposition: Plaintiff's action in negligence dismissed against all four defendants.
  • Reported Related Decisions: Not applicable (High Court decision)

Summary

This High Court decision by Belinda Ang Saw Ean J concerned a claim in medical negligence brought by Ms Noor Azlin Binte Abdul Rahman (the "Plaintiff") against Changi General Hospital Pte Ltd (the "Hospital") and three doctors (Dr Imran bin Mohamed Noor, Dr Yap Hsiang, and Dr Soh Wei Wen Jason, collectively the "defendant-doctors"). The Plaintiff alleged negligent failure to diagnose and treat a pulmonary nodule in her right lung during multiple consultations between 2007 and 2011, before she was ultimately diagnosed with ALK-positive non-small cell lung cancer in 2012. Her central contention was that the nodule was malignant at the material times, and earlier investigation would have led to earlier treatment and a better medical outcome.

The court's analysis focused on two critical elements of negligence: breach of duty and causation. While the court found that Dr Imran had breached his duty by failing to recall the Plaintiff for follow-up on an opacity in 2007, and the Hospital had breached its duty by failing to inform the Plaintiff of the results of her X-ray reports in 2010 and 2011, these breaches were ultimately deemed non-causative. The court found that Dr Yap and Dr Soh had not breached their duties of care. The decisive factor in the dismissal of the Plaintiff's entire action against all defendants was her failure to prove, on a balance of probabilities, that the nodule was malignant at the material times when she consulted the defendants (i.e., between 2007 and 2011).

The judgment provides a detailed examination of how Singapore courts evaluate expert medical evidence, particularly concerning the timing of malignant transformation and the application of the standard of care in diagnostic contexts. It underscores the heavy burden on plaintiffs in medical negligence cases to establish not only a breach of duty but also a direct causal link between that breach and the alleged loss, especially when dealing with evolving medical conditions and knowledge. The court preferred the defendants' expert evidence that the nodule was likely benign initially and only turned malignant later, thereby negating the Plaintiff's claim that earlier intervention would have altered her prognosis.

Timeline of Events

  1. October 2007: Plaintiff attends A&E for chest pain; Dr Yeo orders chest X-ray, noting an opacity in the right mid-zone (the "nodule") and refers her to respiratory medicine.
  2. November 2007: Plaintiff consults Dr Imran, a respiratory specialist, who reviews the October X-ray and orders a repeat X-ray. He concludes no obvious nodule is noted on the repeat X-ray and gives an open date for follow-up.
  3. April 2010: Plaintiff attends A&E for chest pain; Dr Yap spots the nodule on a new X-ray, assesses it as stable compared to earlier images, and discharges her with advice to return if symptoms persist.
  4. July 2011: Plaintiff attends A&E for ribcage pain; Dr Soh orders an X-ray, misses the nodule, diagnoses musculoskeletal pain, and discharges her.
  5. November 2011: Plaintiff seeks care at Raffles Medical Clinic for cough, breathlessness, and blood in sputum.
  6. December 2011: X-ray reveals an opaque lesion; subsequent CT scan recommends a biopsy due to interval increase in size and other features.
  7. February 2012: Biopsy confirms non-small cell lung cancer.
  8. March 2012: Plaintiff undergoes a right lobectomy; diagnosed as Stage IIA.
  9. August 2014: Plaintiff suffers a relapse of cancer, diagnosed as Stage IV.
  10. December 2014: Analysis of the 2012 resected tumour confirms ALK-positive non-small cell lung cancer.
  11. 14 February 2018: High Court delivers judgment, dismissing the Plaintiff's action.

What Were the Facts of This Case?

The Plaintiff, a 38-year-old woman, was diagnosed with non-small cell lung cancer in 2012 following a biopsy of a nodule in her right lung. This cancer was later identified in December 2014 as an anaplastic lymphoma kinase ("ALK")-positive non-small cell lung cancer, caused by an abnormal EML4-ALK gene rearrangement. The Plaintiff's claim in medical negligence focused on the period between 2007 and 2011, during which she had multiple consultations at Changi General Hospital, alleging that the defendants negligently failed to diagnose and treat the nodule earlier.

The nodule was first noted in October 2007 when the Plaintiff attended the Hospital's A&E department for lower chest pain and shortness of breath. A chest X-ray ordered by Dr Yeo showed an opacity in her right mid-zone, prompting a referral to respiratory medicine. Two weeks later, in November 2007, the Plaintiff saw Dr Imran, a respiratory specialist. After reviewing the October X-ray and ordering a repeat, Dr Imran concluded that no obvious nodule was noted on the November X-ray and provided an open date for follow-up, meaning the Plaintiff could return if she felt unwell.

In April 2010, the Plaintiff returned to A&E with similar complaints. Dr Yap attended to her, ordered another chest X-ray, and identified the nodule as an incidental finding. He retrieved the earlier 2007 X-rays, assessed the nodule as stable with no clinically significant changes, and concluded that her symptoms were unrelated to it. After discussing with a senior consultant, Dr Yap discharged the Plaintiff, advising her to return if symptoms persisted. In July 2011, the Plaintiff again attended A&E, this time for left lower ribcage pain. Dr Soh attended to her, ordered a chest X-ray, but missed the nodule in the right lung. He diagnosed musculoskeletal pain and discharged her with painkillers.

The Plaintiff's condition deteriorated in November 2011, when she sought care at a private clinic for cough, breathlessness, and blood in her sputum. A December 2011 X-ray revealed an opaque lesion, and a subsequent referral led to a CT scan and a recommendation for biopsy. The biopsy in February 2012 confirmed lung cancer, leading to a right lobectomy in March 2012. She was initially staged as Stage I, then Stage IIA post-lobectomy. However, she suffered a relapse in August 2014, progressing to Stage IV. The Plaintiff contended that the defendants' delays in detecting the malignancy caused her injury and a worse medical outcome.

The High Court had to address several interconnected legal issues in determining the defendants' liability in medical negligence:

  • Malignancy and Causation: Whether the Plaintiff's pulmonary nodule was malignant at the material times when the defendants assessed her (i.e., between October 2007 and July 2011). This was crucial for establishing causation, as a finding that the nodule was benign at those times would mean the defendants could not have delayed the diagnosis of a cancer the Plaintiff did not yet have.
  • Breach of Duty by Defendant-Doctors: Whether Dr Imran, Dr Yap, and Dr Soh, in their individual consultations, breached the applicable standard of care by failing to adequately investigate or act upon the presence of the nodule, considering the Plaintiff's clinical presentation, age, non-smoking status, and the medical knowledge available at the time.
  • Breach of Duty by the Hospital (Organisational Negligence): Whether the Hospital breached its duty of care by failing to provide a safe system of healthcare, specifically concerning its radiological facilities and services, including the reporting, handling, and communication of X-ray findings to patients. The court also considered, but declined to rule on, whether the Hospital owed a non-delegable duty of care to the Plaintiff.

How Did the Court Analyse the Issues?

The court adopted a structured approach, first addressing the fundamental question of the nodule's malignancy at the material times, as this was determinative of causation. Belinda Ang Saw Ean J stated that she would make findings on whether the nodule was malignant since October 2007 (as the Plaintiff claimed) or whether it was benign and only turned malignant after 31 July 2011 (as the defendants suggested). The court emphasised that the Plaintiff bore the burden of proving that she had cancer when she consulted with the respective defendant-doctors.

On the issue of malignancy and causation, the court preferred the expert evidence of Prof Goh, the defendants' expert, over that of Dr Breen, the Plaintiff's expert. Prof Goh, a clinician scientist with expertise in the biology of malignancy, explained that ALK-positive lung cancers are aggressive. He opined that the Plaintiff's nodule, which was stable and indolent from 2007 to 2011, behaved inconsistently with an ALK-positive cancer. He concluded that the nodule was likely initially benign scar tissue that acquired the ALK gene fusion at some point in 2011 to 2012, resulting in malignancy. The court found this opinion compelling, noting that Dr Breen himself acknowledged the impossibility of definitively stating when the nodule became cancerous without contemporaneous pathology. The court also considered the radiological evidence, which showed stability in the nodule's size and growth between 2007 and 2011, further supporting the benign hypothesis for that period. Crucially, the court found that the Plaintiff had not established on a balance of probabilities that she already had cancer in July 2011.

Regarding the breach of duty by the defendant-doctors, the court assessed each consultation separately against the standard of care applicable at the time. Dr Imran was found to have breached his duty by failing to recall the Plaintiff for a follow-up in November 2007 to ensure the opacity had completely resolved. However, this breach was ultimately deemed non-causative due to the finding that the nodule was likely benign at that time. Dr Yap, who spotted the nodule in April 2010, was found not to have breached his duty. He had retrieved earlier X-rays, assessed the nodule as stable, and discussed the case with a senior consultant, concluding that the symptoms were unrelated to the incidental finding. Dr Soh, who missed the nodule in July 2011, was also found not to have breached his duty, as he diagnosed musculoskeletal pain and discharged the Plaintiff after discussing with a senior doctor.

For the Hospital's alleged breach of duty, the court declined to decide on the question of a non-delegable duty of care, deeming it moot given the findings on causation. On the claim of failing to provide a safe system of healthcare, the court largely found no breach regarding the Hospital's routine reporting system or the routing of abnormal radiological findings to the relevant department for review by senior doctors. However, the court found that the Hospital did breach its duty of care by failing to send the April 2010 and July 2011 X-ray reports with their findings to the Plaintiff, or otherwise communicate these findings. The court reasoned that as part of a safety net, patients should be informed of X-ray results and clinical decisions, even if no further follow-up was deemed necessary by the reviewing doctor, to enable them to seek second opinions if they wished. Despite this finding of breach, it was also held to be non-causative.

What Was the Outcome?

The High Court dismissed the Plaintiff's action in negligence against all four defendants. While the court found that Dr Imran and the Hospital had breached their respective duties of care, these breaches were ultimately determined to be non-causative of the Plaintiff's alleged loss, as she failed to prove that the nodule was malignant at the material times of the consultations. Dr Yap and Dr Soh were found not to have breached their duties.

124 The plaintiff’s action against all the defendants is dismissed. I will hear parties on costs. The parties are to exchange their respective submissions on costs (including on quantum seeing that the parties have submitted their costs schedules) within 21 days hereof. Such submissions shall be limited to 3 pages each.

Why Does This Case Matter?

This case is a significant authority in Singaporean medical negligence law, particularly for claims involving diagnostic failures and incidental findings. Its primary ratio is that a plaintiff must not only establish a breach of duty by a medical professional or institution but also demonstrate, on a balance of probabilities, a direct causal link between that breach and the alleged injury or loss. The court's rigorous approach to causation, especially in the context of an evolving medical condition like cancer, underscores that the timing of a disease's onset or malignant transformation is a critical factual determination that can be decisive.

Doctrinally, the judgment reinforces the principles laid down in leading cases such as Hii Chii Kok v Ooi Peng Jin London Lucien and another [2016] 2 SLR 544 (HC), which outlines the elements of medical negligence. It illustrates the application of the "Bolam test" (or its Singaporean equivalent, the "reasonable body of medical opinion" test) in assessing the standard of care, emphasising that medical practitioners are judged by the knowledge and practices prevalent at the time of the alleged negligence, not by hindsight or later scientific advancements. The detailed discussion on expert evidence highlights the importance of selecting experts whose specialisation directly aligns with the specific medical and scientific questions at hand, particularly concerning the aetiology and progression of diseases.

For practitioners, this case offers several key insights. It serves as a stark reminder that even if a breach of duty can be established, a claim will fail if causation cannot be proven. This necessitates meticulous attention to the medical timeline and the pathological state of the patient at each material point. For both transactional and litigation work, the case underscores the need for clear communication of diagnostic findings to patients, even incidental ones, to mitigate the risk of claims related to informed decision-making. It also provides a template for how courts will scrutinise expert evidence when there are competing theories about disease progression, placing a heavy burden on the plaintiff to provide definitive evidence of malignancy at the relevant times.

Practice Pointers

  • Prioritise Causation Evidence: Even if a breach of duty seems apparent, a medical negligence claim will fail without robust evidence proving that the breach caused the alleged injury. For diagnostic negligence, this means proving the disease was present and treatable at the time of the alleged failure.
  • Expert Witness Selection is Critical: Ensure expert witnesses possess specific expertise directly relevant to the precise medical questions, such as the aetiology, progression, and aggressiveness of the specific disease. General medical experience may be insufficient if the core dispute involves highly specialised pathological or oncological issues.
  • Contemporaneous Standard of Care: When assessing breach of duty, courts will strictly apply the standard of care based on medical knowledge and practice prevalent at the time of the alleged negligence. Avoid arguments that rely on hindsight or medical advancements made subsequent to the incident.
  • Document Patient Communication: Healthcare providers should implement and meticulously document systems for communicating all diagnostic findings, including incidental ones, to patients. This includes X-ray reports and the clinical decisions made, even if no further follow-up is deemed necessary, to ensure patient autonomy and informed decision-making.
  • Burden of Proof for Malignancy Timing: Plaintiffs alleging delayed diagnosis of cancer must adduce definitive medical evidence (e.g., from retrospective pathology review, growth rates, or expert consensus) to prove, on a balance of probabilities, that the lesion was malignant at the specific times of the alleged negligence.
  • Hospital Organisational Systems: Hospitals should regularly review and update their internal systems for handling diagnostic reports, ensuring they are robust, clearly documented, and effectively implemented. While routing reports to departments is good, direct patient notification of results is also a crucial component of a safe system.

Subsequent Treatment

As a High Court decision from 2018, Noor Azlin Bte Abdul Rahman v Changi General Hospital Pte Ltd [2018] SGHC 35 provides a detailed application of established principles of medical negligence, particularly concerning breach of duty and causation. While it does not introduce novel legal doctrines, it serves as a significant reference point for how Singaporean courts rigorously apply the burden of proof, especially regarding the timing of disease onset and the causal link between alleged negligence and harm. The case clarifies the high evidential bar for plaintiffs in diagnostic negligence claims, particularly in proving that a missed diagnosis related to a condition that was already malignant at the material time. It is likely to be cited in subsequent medical negligence cases for its comprehensive analysis of expert evidence and its emphasis on the non-causative nature of breaches where the underlying medical reality (e.g., benignity of a nodule) is not proven otherwise.

Legislation Referenced

  • Evidence Act (Cap 97, 1997 Rev Ed), s 103(1)
  • Evidence Act (Cap 97, 1997 Rev Ed), s 104
  • Evidence Act (Cap 97, 1997 Rev Ed), s 105

Cases Cited

  • Hii Chii Kok v Ooi Peng Jin London Lucien and another [2016] 2 SLR 544: Cited for leaving open the question of whether hospitals owe non-delegable duties to patients.
  • Tiong Aik Construction Pte Ltd v Chng Chor Hua [2017] 1 SLR 324: Cited for cautioning against deciding on non-delegable duties where unnecessary.
  • Wilsher v Essex Area Health Authority [1988] AC 1074: Cited as an English authority on a hospital's direct liability for organisational failure.

Source Documents

Written by Sushant Shukla
1.5×

More in

Legal Wires

Legal Wires

Stay ahead of the legal curve. Get expert analysis and regulatory updates natively delivered to your inbox.

Success! Please check your inbox and click the link to confirm your subscription.